An approach for identifying in silico peptides against authentic metabolites: in vitro characterization of thymosin β4 metabolites
Authors:
- 8 July 2022
- journal article
- research article
- Published by Springer Nature in Journal of Pharmaceutical Investigation
- Vol. 52 (5) , 611-621
Abstract
No abstract availableKeywords
Funding Information
- Korea Institute of Science and Technology (2V06980)
This publication has 22 references indexed in Scilit:
- Research Applications of Proteolytic Enzymes in Molecular BiologyBiomolecules, 2013
- ADME of Biologics—What Have We Learned from Small Molecules?The AAPS Journal, 2012
- Animal studies with thymosin β4, a multifunctional tissue repair and regeneration peptideAnnals of the New York Academy of Sciences, 2010
- The use ofin vitrotechnologies coupled with high resolution accurate mass LC‐MS for studying drug metabolism in equine drug surveillanceDrug Testing and Analysis, 2010
- Medical progress depends on animal models - doesn't it?Journal of the Royal Society of Medicine, 2008
- Development of Thymosin β4 for Treatment of Patients with Ischemic Heart DiseaseAnnals of the New York Academy of Sciences, 2007
- Thymosin β: actin-sequestering protein moonlights to repair injured tissuesTrends in Molecular Medicine, 2005
- Systemic Availability and Lymphatic Transport of Human Growth Hormone Administered by Subcutaneous InjectionJournal of Pharmaceutical Sciences, 2000
- Thymosin β4 Accelerates Wound HealingJournal of Investigative Dermatology, 1999
- The Use of In Vitro Metabolism Techniques in the Planning and Interpretation of Drug Safety StudiesToxicologic Pathology, 1995